Intravenous Administration of Microplasmin for Treatment of Acute Ischemic Stroke

Mise à jour : Il y a 4 ans
Référence : NCT00123305

Femme et Homme

Extrait

The primary purpose of this study is to evaluate the safety and preliminary efficacy of microplasmin when administered intravenously to patients who have suffered an acute stroke within 12 hours before randomization.


Critère d'inclusion

  • Stroke Acute

Liens